Annual Cash & Cash Equivalents
$1.64 M
-$1.88 M-53.31%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual cash & cash equivalents is $1.64 million, with the most recent change of -$1.88 million (-53.31%) on December 31, 2023.
- During the last 3 years, VVOS annual cash & cash equivalents has fallen by -$16.56 million (-90.98%).
- VVOS annual cash & cash equivalents is now -93.16% below its all-time high of $24.03 million, reached on December 31, 2021.
Performance
VVOS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.31 M
-$592.00 K-8.58%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly cash and cash equivalents is $6.31 million, with the most recent change of -$592.00 thousand (-8.58%) on September 30, 2024.
- Over the past year, VVOS quarterly cash and cash equivalents has stayed the same.
- VVOS quarterly cash and cash equivalents is now -81.55% below its all-time high of $34.20 million, reached on June 30, 2021.
Performance
VVOS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VVOS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.3% | 0.0% |
| 3 y3 years | -91.0% | -77.9% |
| 5 y5 years | +30.9% | -55.1% |
VVOS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.2% | at low | -73.7% | +538.8% |
| 5 y | 5-year | -93.2% | +250.0% | -81.5% | +1425.9% |
| alltime | all time | -93.2% | +250.0% | -81.5% | +1425.9% |
Vivos Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.31 M(-8.6%) |
| Jun 2024 | - | $6.90 M(+164.4%) |
| Mar 2024 | - | $2.61 M(+58.9%) |
| Dec 2023 | $1.64 M(-53.3%) | $1.64 M(+66.3%) |
| Sep 2023 | - | $988.00 K(-74.9%) |
| Jun 2023 | - | $3.94 M(-44.1%) |
| Mar 2023 | - | $7.05 M(+100.2%) |
| Dec 2022 | $3.52 M | $3.52 M(-47.6%) |
| Sep 2022 | - | $6.72 M(-46.9%) |
| Jun 2022 | - | $12.66 M(-29.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $17.83 M(-25.8%) |
| Dec 2021 | $24.03 M(+32.0%) | $24.03 M(-15.8%) |
| Sep 2021 | - | $28.53 M(-16.6%) |
| Jun 2021 | - | $34.20 M(+143.3%) |
| Mar 2021 | - | $14.06 M(-22.8%) |
| Dec 2020 | $18.21 M(+3778.6%) | $18.21 M(+1074.5%) |
| Sep 2020 | - | $1.55 M(+274.8%) |
| Jun 2020 | - | $413.60 K(-11.9%) |
| Dec 2019 | $469.40 K(-62.6%) | $469.40 K |
| Dec 2018 | $1.25 M | - |
FAQ
- What is Vivos Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vivos Therapeutics?
- What is Vivos Therapeutics annual cash & cash equivalents year-on-year change?
- What is Vivos Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Vivos Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of VVOS is $1.64 M
What is the all time high annual cash & cash equivalents for Vivos Therapeutics?
Vivos Therapeutics all-time high annual cash & cash equivalents is $24.03 M
What is Vivos Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, VVOS annual cash & cash equivalents has changed by -$1.88 M (-53.31%)
What is Vivos Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VVOS is $6.31 M
What is the all time high quarterly cash and cash equivalents for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly cash and cash equivalents is $34.20 M
What is Vivos Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, VVOS quarterly cash and cash equivalents has changed by $0.00 (0.00%)